The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Invasive Fungal Infection-Global Market Insights and Sales Trends 2024
Synopsis
Invasive fungal infection refers to the pathological changes and pathophysiological processes of fungi that invade human tissues and blood, and grow and multiply in them, leading to tissue damage, organ dysfunction, and inflammation.
The global Invasive Fungal Infection market size is expected to reach US$ 13980 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Invasive Fungal Infection in various end use industries. The expanding demands from the Yeast-like Fungi, Filamentous Fungi and Other,, are propelling Invasive Fungal Infection market. Diagnosis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Treatment segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Invasive Fungal Infection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Invasive Fungal Infection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Invasive Fungal Infection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Invasive Fungal Infection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Invasive Fungal Infection covered in this report include Cidara Therapeutics, Basilea Pharmaceutica, Pfizer, GlaxoSmithKline, Bayer, Abbott, Merck, Astellas Pharma and F2G, etc.
The global Invasive Fungal Infection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cidara Therapeutics
Basilea Pharmaceutica
Pfizer
GlaxoSmithKline
Bayer
Abbott
Merck
Astellas Pharma
F2G
Scynexis
Associates of Cape Cod
BioRad
IMMY
Beijing Jinshanchuan
Danna Biological
Zhanjiang A and C Biological
Global Invasive Fungal Infection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Invasive Fungal Infection market, Segment by Type:
Diagnosis
Treatment
Global Invasive Fungal Infection market, by Application
Yeast-like Fungi
Filamentous Fungi
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Invasive Fungal Infection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Invasive fungal infection refers to the pathological changes and pathophysiological processes of fungi that invade human tissues and blood, and grow and multiply in them, leading to tissue damage, organ dysfunction, and inflammation.
The global Invasive Fungal Infection market size is expected to reach US$ 13980 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Invasive Fungal Infection in various end use industries. The expanding demands from the Yeast-like Fungi, Filamentous Fungi and Other,, are propelling Invasive Fungal Infection market. Diagnosis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Treatment segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Invasive Fungal Infection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Invasive Fungal Infection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Invasive Fungal Infection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Invasive Fungal Infection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Invasive Fungal Infection covered in this report include Cidara Therapeutics, Basilea Pharmaceutica, Pfizer, GlaxoSmithKline, Bayer, Abbott, Merck, Astellas Pharma and F2G, etc.
The global Invasive Fungal Infection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cidara Therapeutics
Basilea Pharmaceutica
Pfizer
GlaxoSmithKline
Bayer
Abbott
Merck
Astellas Pharma
F2G
Scynexis
Associates of Cape Cod
BioRad
IMMY
Beijing Jinshanchuan
Danna Biological
Zhanjiang A and C Biological
Global Invasive Fungal Infection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Invasive Fungal Infection market, Segment by Type:
Diagnosis
Treatment
Global Invasive Fungal Infection market, by Application
Yeast-like Fungi
Filamentous Fungi
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Invasive Fungal Infection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Invasive Fungal Infection
1.1 Invasive Fungal Infection Market Overview
1.1.1 Invasive Fungal Infection Product Scope
1.1.2 Invasive Fungal Infection Market Status and Outlook
1.2 Global Invasive Fungal Infection Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Invasive Fungal Infection Market Size by Region (2018-2029)
1.4 Global Invasive Fungal Infection Historic Market Size by Region (2018-2023)
1.5 Global Invasive Fungal Infection Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Invasive Fungal Infection Market Size (2018-2029)
1.6.1 North America Invasive Fungal Infection Market Size (2018-2029)
1.6.2 Europe Invasive Fungal Infection Market Size (2018-2029)
1.6.3 Asia-Pacific Invasive Fungal Infection Market Size (2018-2029)
1.6.4 Latin America Invasive Fungal Infection Market Size (2018-2029)
1.6.5 Middle East & Africa Invasive Fungal Infection Market Size (2018-2029)
2 Invasive Fungal Infection Market by Type
2.1 Introduction
2.1.1 Diagnosis
2.1.2 Treatment
2.2 Global Invasive Fungal Infection Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Invasive Fungal Infection Historic Market Size by Type (2018-2023)
2.2.2 Global Invasive Fungal Infection Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Invasive Fungal Infection Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Invasive Fungal Infection Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Invasive Fungal Infection Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Invasive Fungal Infection Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Invasive Fungal Infection Revenue Breakdown by Type (2018-2029)
3 Invasive Fungal Infection Market Overview by Application
3.1 Introduction
3.1.1 Yeast-like Fungi
3.1.2 Filamentous Fungi
3.1.3 Other
3.2 Global Invasive Fungal Infection Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Invasive Fungal Infection Historic Market Size by Application (2018-2023)
3.2.2 Global Invasive Fungal Infection Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Invasive Fungal Infection Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Invasive Fungal Infection Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Invasive Fungal Infection Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Invasive Fungal Infection Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Invasive Fungal Infection Revenue Breakdown by Application (2018-2029)
4 Invasive Fungal Infection Competition Analysis by Players
4.1 Global Invasive Fungal Infection Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Invasive Fungal Infection as of 2022)
4.3 Date of Key Players Enter into Invasive Fungal Infection Market
4.4 Global Top Players Invasive Fungal Infection Headquarters and Area Served
4.5 Key Players Invasive Fungal Infection Product Solution and Service
4.6 Competitive Status
4.6.1 Invasive Fungal Infection Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Cidara Therapeutics
5.1.1 Cidara Therapeutics Profile
5.1.2 Cidara Therapeutics Main Business
5.1.3 Cidara Therapeutics Invasive Fungal Infection Products, Services and Solutions
5.1.4 Cidara Therapeutics Invasive Fungal Infection Revenue (US$ Million) & (2018-2023)
5.1.5 Cidara Therapeutics Recent Developments
5.2 Basilea Pharmaceutica
5.2.1 Basilea Pharmaceutica Profile
5.2.2 Basilea Pharmaceutica Main Business
5.2.3 Basilea Pharmaceutica Invasive Fungal Infection Products, Services and Solutions
5.2.4 Basilea Pharmaceutica Invasive Fungal Infection Revenue (US$ Million) & (2018-2023)
5.2.5 Basilea Pharmaceutica Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Invasive Fungal Infection Products, Services and Solutions
5.3.4 Pfizer Invasive Fungal Infection Revenue (US$ Million) & (2018-2023)
5.3.5 GlaxoSmithKline Recent Developments
5.4 GlaxoSmithKline
5.4.1 GlaxoSmithKline Profile
5.4.2 GlaxoSmithKline Main Business
5.4.3 GlaxoSmithKline Invasive Fungal Infection Products, Services and Solutions
5.4.4 GlaxoSmithKline Invasive Fungal Infection Revenue (US$ Million) & (2018-2023)
5.4.5 GlaxoSmithKline Recent Developments
5.5 Bayer
5.5.1 Bayer Profile
5.5.2 Bayer Main Business
5.5.3 Bayer Invasive Fungal Infection Products, Services and Solutions
5.5.4 Bayer Invasive Fungal Infection Revenue (US$ Million) & (2018-2023)
5.5.5 Bayer Recent Developments
5.6 Abbott
5.6.1 Abbott Profile
5.6.2 Abbott Main Business
5.6.3 Abbott Invasive Fungal Infection Products, Services and Solutions
5.6.4 Abbott Invasive Fungal Infection Revenue (US$ Million) & (2018-2023)
5.6.5 Abbott Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Invasive Fungal Infection Products, Services and Solutions
5.7.4 Merck Invasive Fungal Infection Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Recent Developments
5.8 Astellas Pharma
5.8.1 Astellas Pharma Profile
5.8.2 Astellas Pharma Main Business
5.8.3 Astellas Pharma Invasive Fungal Infection Products, Services and Solutions
5.8.4 Astellas Pharma Invasive Fungal Infection Revenue (US$ Million) & (2018-2023)
5.8.5 Astellas Pharma Recent Developments
5.9 F2G
5.9.1 F2G Profile
5.9.2 F2G Main Business
5.9.3 F2G Invasive Fungal Infection Products, Services and Solutions
5.9.4 F2G Invasive Fungal Infection Revenue (US$ Million) & (2018-2023)
5.9.5 F2G Recent Developments
5.10 Scynexis
5.10.1 Scynexis Profile
5.10.2 Scynexis Main Business
5.10.3 Scynexis Invasive Fungal Infection Products, Services and Solutions
5.10.4 Scynexis Invasive Fungal Infection Revenue (US$ Million) & (2018-2023)
5.10.5 Scynexis Recent Developments
5.11 Associates of Cape Cod
5.11.1 Associates of Cape Cod Profile
5.11.2 Associates of Cape Cod Main Business
5.11.3 Associates of Cape Cod Invasive Fungal Infection Products, Services and Solutions
5.11.4 Associates of Cape Cod Invasive Fungal Infection Revenue (US$ Million) & (2018-2023)
5.11.5 Associates of Cape Cod Recent Developments
5.12 BioRad
5.12.1 BioRad Profile
5.12.2 BioRad Main Business
5.12.3 BioRad Invasive Fungal Infection Products, Services and Solutions
5.12.4 BioRad Invasive Fungal Infection Revenue (US$ Million) & (2018-2023)
5.12.5 BioRad Recent Developments
5.13 IMMY
5.13.1 IMMY Profile
5.13.2 IMMY Main Business
5.13.3 IMMY Invasive Fungal Infection Products, Services and Solutions
5.13.4 IMMY Invasive Fungal Infection Revenue (US$ Million) & (2018-2023)
5.13.5 IMMY Recent Developments
5.14 Beijing Jinshanchuan
5.14.1 Beijing Jinshanchuan Profile
5.14.2 Beijing Jinshanchuan Main Business
5.14.3 Beijing Jinshanchuan Invasive Fungal Infection Products, Services and Solutions
5.14.4 Beijing Jinshanchuan Invasive Fungal Infection Revenue (US$ Million) & (2018-2023)
5.14.5 Beijing Jinshanchuan Recent Developments
5.15 Danna Biological
5.15.1 Danna Biological Profile
5.15.2 Danna Biological Main Business
5.15.3 Danna Biological Invasive Fungal Infection Products, Services and Solutions
5.15.4 Danna Biological Invasive Fungal Infection Revenue (US$ Million) & (2018-2023)
5.15.5 Danna Biological Recent Developments
5.16 Zhanjiang A and C Biological
5.16.1 Zhanjiang A and C Biological Profile
5.16.2 Zhanjiang A and C Biological Main Business
5.16.3 Zhanjiang A and C Biological Invasive Fungal Infection Products, Services and Solutions
5.16.4 Zhanjiang A and C Biological Invasive Fungal Infection Revenue (US$ Million) & (2018-2023)
5.16.5 Zhanjiang A and C Biological Recent Developments
6 North America
6.1 North America Invasive Fungal Infection Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Invasive Fungal Infection Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Invasive Fungal Infection Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Invasive Fungal Infection Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Invasive Fungal Infection Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Invasive Fungal Infection Market Dynamics
11.1 Invasive Fungal Infection Industry Trends
11.2 Invasive Fungal Infection Market Drivers
11.3 Invasive Fungal Infection Market Challenges
11.4 Invasive Fungal Infection Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
